Vimarsana.com

Latest Breaking News On - Taysha gene therapies inc - Page 7 : vimarsana.com

Taysha Gene Therapies Reports Third Quarter 2023 Financial Results and Provides Corporate and Clinical Updates

Taysha Gene Therapies Reports Third Quarter 2023 Financial Results and Provides Corporate and Clinical Updates
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

Canada
United-states
Dallas
Texas
Seanp-nolan
Hayleigh-collins
Elsa-rossignol
Carolyn-hawley
Head-of-corporate-communications
Regulatory-agency
Company-contact
Taysha-gene-therapies-inc

Taysha Gene Therapies Reports Third Quarter 2023 Financial

Data from first adult patient in REVEAL Phase 1/2 trial showed TSHA-102 was well-tolerated with no treatment-emergent SAEs as of 20-week assessment with.

Dallas
Texas
United-states
Canada
Carolyn-hawley
Elsa-rossignol
Hayleigh-collins
Seanp-nolan
Taysha-gene-therapies-inc
Development-expenses
Canale-communications
Silicon-valley-bank

Taysha Gene Therapies Reports Third Quarter 2023 Financial Results and Provides Corporate and Clinical Updates

Taysha Gene Therapies Reports Third Quarter 2023 Financial Results and Provides Corporate and Clinical Updates
forextv.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from forextv.com Daily Mail and Mail on Sunday newspapers.

Canada
United-states
Dallas
Texas
Hayleigh-collins
Seanp-nolan
Carolyn-hawley
Elsa-rossignol
Company-contact
Regulatory-agency
Head-of-corporate-communications
European-society-of-gene-cell-therapy

Taysha Gene Therapies: TSHA-102's Potential Is A 'Buy' (NASDAQ:TSHA)

Taysha Gene Therapies: TSHA-102's Potential Is A 'Buy' (NASDAQ:TSHA)
seekingalpha.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from seekingalpha.com Daily Mail and Mail on Sunday newspapers.

Canada
United-kingdom
United-states
Nasdaq
European-union
Taysha-gene-therapies-inc
European-society-of-gene-cell-therapy
Regenerative-medicine
Gene-therapies
Central-nervous-system
Track-designation

DelveInsight Business Research, LLP: In-Depth Analysis of Mucopolysaccharidosis Market and its Subtypes: Mucopolysaccharidosis I, Mucopolysaccharidosis II, Mucopolysaccharidosis III, Mucopolysaccharidosis IV, and Mucopolysaccharidosis VII

DelveInsight Business Research, LLP: In-Depth Analysis of Mucopolysaccharidosis Market and its Subtypes: Mucopolysaccharidosis I, Mucopolysaccharidosis II, Mucopolysaccharidosis III, Mucopolysaccharidosis IV, and Mucopolysaccharidosis VII
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

United-states
Japan
American
Vifor-pharma
Ihre-chancen
Prnewswire-delveinsight-mucopolysaccharidosis
Indiens-wirtschaft
Shruti-thakur
Beam-therapeutics-inc
Forma-therapeutics-inc
Taysha-gene-therapies-inc
Intrabio-inc

Taysha Gene Therapies, Inc. (NASDAQ:TSHA) Receives $7.91 Consensus PT from Analysts

Taysha Gene Therapies, Inc. (NASDAQ:TSHA) Receives $7.91 Consensus PT from Analysts
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

Switzerland
Swiss
Paulb-manning
Kamran-alam
Securities-exchange-commission
Needham-company
Nantahala-capital-management
Quantum-private-wealth
Cantor-fitzgerald
Taysha-gene-therapies-inc
Swiss-national-bank
Commonwealth-equity-services

Short Interest in Taysha Gene Therapies, Inc. (NASDAQ:TSHA) Increases By 34.9%

Taysha Gene Therapies, Inc. (NASDAQ:TSHA – Get Free Report) was the target of a large growth in short interest in September. As of September 15th, there was short interest totalling 9,930,000 shares, a growth of 34.9% from the August 31st total of 7,360,000 shares. Based on an average daily volume of 4,830,000 shares, the days-to-cover […]

Robertw-baird
Kamran-alam
Capital-management
Dynamic-advisor-solutions
Commonwealth-equity-services
Needham-company
Nasdaq
Virtu-financial
Taysha-gene-therapies-inc
Maven-securities
Canaccord-genuity-group
Taysha-gene-therapies

vimarsana © 2020. All Rights Reserved.